Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a8cb413d5b9e38b57b97e9e9a8c7f9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c502d897dc11e9ff4846bdec1b127 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 |
filingDate |
1998-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ee3188acf7c49b70a2afbf72e26ffb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8418d90c03bb18544b6286e645e811d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215eda6ed20f5f1e42d2d74154ca9c8f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_322419ea94a4ef060d30c2ea8c166613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576858756335fe2916207d75fb2bab51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d746f8ac5f8af2868d9adad78c7e1cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_727ea8cb53ac96d19f5beafa70963604 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bbc038ebefd73d169f3bc1d87ac9d60 |
publicationDate |
1999-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2134107-C1 |
titleOfInvention |
Preparation "gistokhrom" for treatment of eye retina and cornea inflammatory sicknesses |
abstract |
FIELD: medicine, ophthalmology. SUBSTANCE: invention relates to preparations used for treatment of sicknesses associated with metabolic disorders and eye retina and cornea inflammation. Drug is 0.02% isotonic solution of equinochrome di- and trisodium salt ("Gistokhrom"). This drug is used in sicknesses associated with disorder of metabolic and inflammatory processes in retina, vascular membrane and cornea for improvement of trophics, edema decrease and acceleration of epithelization. Drug is used in proliferative processes, degenerations and hemophthalms of different genesis and in contusia and eye penetrating wounding also. Drug shows retinoprotective, anti-inflammatory and anticataractous properties and shows good tolerance by patients. EFFECT: enhanced effectiveness of preparation. 1 ex |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2488402-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2554776-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2510254-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2498570-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2684783-C1 |
priorityDate |
1998-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |